1. M Ruiz-Ortega, S Rayego-Mateos, S Lamas, A Ortiz and Nephrology Rodrigues-Diez RR %J Nature reviews. Targeting the progression of chronic kidney disease. 2020.
2. medicine Ortiz A %J EMBO molecular. PDGFR-β and kidney fibrosis. 2020:
3. K Matsushita, SH Ballew, J Coresh, H Arima, J Ärnlöv, M Cirillo, N Ebert, JS Hiramoto, H Kimm, MG Shlipak, FLJ Visseren, RT Gansevoort, CP Kovesdy, et al. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. 2017; 5(9):718-728.
4. KR Tuttle, MC Lakshmanan, B Rayner, RS Busch, AG Zimmermann, DB Woodward, Diabetes Botros FT %J The lancet. and endocrinology. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial. 2018; 6(8):605-617.
5. S Beddhu, T Greene, R Boucher, WC Cushman, G Wei, G Stoddard, JH Ix, M Chonchol, H Kramer, AK Cheung, PL Kimmel, PK Whelton, Diabetes Chertow GM %J The lancet., et al. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. 2018; 6(7):555-563.
6. SS Waikar, A Srivastava, R Palsson, T Shafi, CY Hsu, K Sharma, JP Lash, J Chen, J He, J Lieske, D Xie, X Zhang, HI Feldman, et al. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression. 2019; 179(4):542-551.
7. J Tang, D Yao, H Yan, X Chen, L Wang and endocrinology Zhan H %J International journal of. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy. 2019; 2019:
8. Y Jia, Z Zheng, M Guan, Q Zhang, Y Li, L Wang, Experimental Xue Y %J and medicine molecular. Exendin-4 ameliorates high glucose-induced fibrosis by inhibiting the secretion of miR-192 from injured renal tubular epithelial cells. 2018; 50(5):
9. AC Chung and physiology Lan HY %J Frontiers in. MicroRNAs in renal fibrosis. 2015; 6:
10. B Wang, R Komers, R Carew, CE Winbanks, B Xu, M Herman-Edelstein, P Koh, M Thomas, K Jandeleit-Dahm, P Gregorevic, ME Cooper and JASN Kantharidis P %J Journal of the American Society of Nephrology :. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. 2012; 23(2):252-265.
11. Y Fang, X Yu, Y Liu, AJ Kriegel, Y Heng, X Xu, M Liang and physiology Ding X %J American journal of physiology. Renal. miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation. 2013; 304(10):F1274-1282.
12. Y He, C Huang, X Lin and Biochimie Li J %J. MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. 2013; 95(7):1355-1359.
13. V Ramdas, M McBride, L Denby and pathology Baker AH %J The American journal of. Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29. 2013; 183(6):1885-1896.
14. G Cao, S Li, H Shi, P Yin, J Chen, H Li, Y Zhong, LT Diao, Toxicology Du B %J and pharmacology applied. Schisandrin B attenuates renal fibrosis via miR-30e-mediated inhibition of EMT. 2019; 385:
15. R Yang, X Xu, H Li, J Chen, X Xiang, Z Dong and reports Zhang D %J Scientific. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO. 2017; 7:
16. H Xia, LL Ooi and Hepatology Hui KM %J. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. 2013; 58(2):629-641.
17. N Faherty, SP Curran, H O'Donovan, F Martin, C Godson, DP Brazil and science Crean JK %J Journal of cell. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes. 2012; 125:5621-5629.
18. AJ Tompkins, D Chatterjee, M Maddox, J Wang, E Arciero, G Camussi, PJ Quesenberry and vesicles Renzulli JF %J Journal of extracellular. The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy. 2015; 4:
19. SR Khan, DE Rodriguez, LB Gower and urology Monga M %J The Journal of. Association of Randall plaque with collagen fibers and membrane vesicles. 2012; 187(3):1094-1100.
20. C Beltrami, M Besnier, S Shantikumar, AI Shearn, C Rajakaruna, A Laftah, F Sessa, G Spinetti, E Petretto, GD Angelini and Therapy Emanueli C %J Molecular therapy : the journal of the American Society of Gene. Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis. 2017; 25(3):679-693.
21. B Wang, C Zhang, A Zhang, H Cai, SR Price and JASN Wang XH %J Journal of the American Society of Nephrology :. MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy. 2017; 28(9):2631-2640.
22. Wang B., Zhang C., Zhang A., Cai H., Price S. R. and Wang X. H. MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy. J Am Soc Nephrol. 2017; 28(9):2631-2640.
23. DQ Chen, G Cao, H Chen, CP Argyopoulos, H Yu, W Su, L Chen, DC Samuels, S Zhuang, GP Bayliss, S Zhao, XY Yu, ND Vaziri, et al. Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan. 2019; 10(1):
24. B Roediger, Q Lee, S Tikoo, JCA Cobbin, JM Henderson, M Jormakka, MB O'Rourke, MP Padula, N Pinello, M Henry, M Wynne, SF Santagostino, CF Brayton, et al. An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis. 2018; 175(2):530-543.e524.
25. P Romagnani, G Remuzzi, R Glassock, A Levin, KJ Jager, M Tonelli, Z Massy, C Wanner and primers Anders HJ %J Nature reviews. Disease. Chronic kidney disease. 2017; 3:
26. XM Meng, DJ Nikolic-Paterson and Nephrology Lan HY %J Nature reviews. TGF-β: the master regulator of fibrosis. 2016; 12(6):325-338.
27. C Solé, J Cortés-Hernández, ML Felip, M Vidal, Ordi-Ros J %J Nephrology dialysis, transplantation : official publication of the European Dialysis and Association Transplant Association - European Renal. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. 2015; 30(9):1488-1496.
28. A Zhang, M Li, B Wang, JD Klein, SR Price, Wang XH %J Journal of cachexia sarcopenia and muscle. miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk. 2018; 9(4):755-770.
29. B Wang, K Yao, BM Huuskes, HH Shen, J Zhuang, C Godson, EP Brennan, JL Wilkinson-Berka, AF Wise and Therapy Ricardo SD %J Molecular therapy : the journal of the American Society of Gene. Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis. 2016; 24(7):1290-1301.